This phase 2 trial also identified a subset of patients with specific mutations who may see the most benefit from the drug.

When the surgical wound doesn’t heal right, it can send some patients back to the operating room.

Researchers find infiltrating lymphocytes tie to survival in patients with recurrent larynx cancer; findings suggest super-boosting the immune system before additional treatment.

A new study finds exceptional long-term survival when a single dose of chemotherapy selects patients for chemoradiation or surgery.

A new study identifies a biomarker that rises just before patients’ cancer comes back — which could provide a window for earlier treatment.

New research explores how a patient’s own immune system might help determine effective treatment options for head and neck cancer.